These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 1978619)

  • 21. A randomized, double-blind, single-dose, crossover clinical trial of the onset and duration of protection from exercise-induced bronchoconstriction by formoterol and albuterol.
    Shapiro GS; Yegen U; Xiang J; Kottakis J; Della Cioppa G
    Clin Ther; 2002 Dec; 24(12):2077-87. PubMed ID: 12581546
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The duration of action of inhaled formoterol dry powder.
    Quebe-Fehling E; Brambilla R; Bromly CL; Fishwick K; Walters EH; Hendrick DJ
    Br J Clin Pract; 1996 Dec; 50(8):446-9. PubMed ID: 9039716
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vivo effect of albuterol on methacholine-contracted bronchi in conjunction with salmeterol and formoterol.
    Aziz I; Lipworth BJ
    J Allergy Clin Immunol; 1999 May; 103(5 Pt 1):816-22. PubMed ID: 10329815
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Assessment of a relative therapeutic index between inhaled formoterol and salbuterol in asthma patients.
    Rosenborg J; Larsson P; Rott Z; Böcskei C; Poczi M; Juhász G
    Eur J Clin Pharmacol; 2002 Jul; 58(4):S61-7. PubMed ID: 12214580
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regular formoterol treatment in mild asthma. Effect on bronchial responsiveness during and after treatment.
    Yates DH; Sussman HS; Shaw MJ; Barnes PJ; Chung KF
    Am J Respir Crit Care Med; 1995 Oct; 152(4 Pt 1):1170-4. PubMed ID: 7551366
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhaled corticosteroids, combined with long-acting beta(2)-agonists, improve the perception of bronchoconstriction in asthma.
    Bijl-Hofland ID; Cloosterman SG; Folgering HT; van den Elshout FJ; van Weel C; van Schayck CP
    Am J Respir Crit Care Med; 2001 Sep; 164(5):764-9. PubMed ID: 11549530
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rapid onset of tolerance to beta-agonist bronchodilation.
    Haney S; Hancox RJ
    Respir Med; 2005 May; 99(5):566-71. PubMed ID: 15823453
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhaled formoterol during one year in asthma: a comparison with salbutamol.
    Arvidsson P; Larsson S; Löfdahl CG; Melander B; Svedmyr N; Wåhlander L
    Eur Respir J; 1991 Nov; 4(10):1168-73. PubMed ID: 1687129
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Formoterol, a new long-acting selective beta 2-adrenergic receptor agonist: double-blind comparison with salbutamol and placebo in children with asthma.
    Becker AB; Simons FE
    J Allergy Clin Immunol; 1989 Dec; 84(6 Pt 1):891-5. PubMed ID: 2574732
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of the effects of salmeterol and formoterol on airway tone and responsiveness over 24 hours in bronchial asthma.
    Rabe KF; Jörres R; Nowak D; Behr N; Magnussen H
    Am Rev Respir Dis; 1993 Jun; 147(6 Pt 1):1436-41. PubMed ID: 8503554
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Asthma control during and after cessation of regular beta 2-agonist treatment.
    Wahedna I; Wong CS; Wisniewski AF; Pavord ID; Tattersfield AE
    Am Rev Respir Dis; 1993 Sep; 148(3):707-12. PubMed ID: 8103655
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bronchodilator effect of inhaled formoterol vs salbutamol over 12 hours.
    Maesen FP; Smeets JJ; Gubbelmans HL; Zweers PG
    Chest; 1990 Mar; 97(3):590-4. PubMed ID: 1968371
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A study of the duration of the bronchodilator effect of 12 micrograms and 24 micrograms of inhaled formoterol and 200 micrograms inhaled salbutamol in asthma.
    Sykes AP; Ayres JG
    Respir Med; 1990 Mar; 84(2):135-8. PubMed ID: 2371435
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhaled lignocaine does not alter bronchial hyperresponsiveness to hyperventilation of dry cold air in asthmatic subjects.
    Caire N; Cartier A; Ghezzo H; L'Archevêque J; Malo JL
    Clin Exp Allergy; 1989 Jan; 19(1):65-70. PubMed ID: 2702512
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy of inhaled formoterol in reversing bronchoconstriction.
    Rubin AS; Perin C; Pelegrin L; Fernandes JC; da Silva LC
    J Bras Pneumol; 2006; 32(3):202-6. PubMed ID: 17273608
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Theophylline minimally inhibits bronchoconstriction induced by dry cold air inhalation in asthmatic subjects.
    Merland N; Cartier A; L'Archevêque J; Ghezzo H; Malo JL
    Am Rev Respir Dis; 1988 Jun; 137(6):1304-8. PubMed ID: 3202370
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reversing acute bronchoconstriction in asthma: the effect of bronchodilator tolerance after treatment with formoterol.
    Jones SL; Cowan JO; Flannery EM; Hancox RJ; Herbison GP; Taylor DR
    Eur Respir J; 2001 Mar; 17(3):368-73. PubMed ID: 11405513
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long duration of airway but not systemic effects of inhaled formoterol in asthmatic patients.
    Lötvall J; Ankerst J
    Respir Med; 2008 Mar; 102(3):449-56. PubMed ID: 18023335
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An inhaled glucocorticoid does not prevent tolerance to the bronchoprotective effect of a long-acting inhaled beta 2-agonist.
    Yates DH; Kharitonov SA; Barnes PJ
    Am J Respir Crit Care Med; 1996 Dec; 154(6 Pt 1):1603-7. PubMed ID: 8970342
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of the relative efficacy of formoterol and salmeterol in asthmatic patients.
    Palmqvist M; Ibsen T; Mellén A; Lötvall J
    Am J Respir Crit Care Med; 1999 Jul; 160(1):244-9. PubMed ID: 10390407
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.